PHIA Stock Overview
Operates as a health technology company in North America, the Greater China, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 4/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Koninklijke Philips N.V. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €24.42 |
| 52 Week High | €30.11 |
| 52 Week Low | €17.52 |
| Beta | 0.79 |
| 11 Month Change | -17.36% |
| 3 Month Change | -7.78% |
| 1 Year Change | 30.87% |
| 33 Year Change | -24.35% |
| 5 Year Change | -35.26% |
| Change since IPO | -24.67% |
Recent News & Updates
Recent updates
Shareholder Returns
| PHIA | AT Medical Equipment | AT Market | |
|---|---|---|---|
| 7D | -2.5% | -2.4% | 0.9% |
| 1Y | 30.9% | 13.2% | 1.5% |
Return vs Industry: PHIA exceeded the Austrian Medical Equipment industry which returned 13.2% over the past year.
Return vs Market: PHIA exceeded the Austrian Market which returned 1.5% over the past year.
Price Volatility
| PHIA volatility | |
|---|---|
| PHIA Average Weekly Movement | 6.0% |
| Medical Equipment Industry Average Movement | 6.2% |
| Market Average Movement | 3.6% |
| 10% most volatile stocks in AT Market | 6.3% |
| 10% least volatile stocks in AT Market | 1.8% |
Stable Share Price: PHIA's share price has been volatile over the past 3 months compared to the Austrian market.
Volatility Over Time: PHIA's weekly volatility (6%) has been stable over the past year, but is still higher than 75% of Austrian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1891 | 68,701 | Roy Jakobs | www.philips.com |
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
Koninklijke Philips N.V. Fundamentals Summary
| PHIA fundamental statistics | |
|---|---|
| Market cap | €22.95b |
| Earnings (TTM) | -€469.00m |
| Revenue (TTM) | €18.04b |
1.3x
P/S Ratio-48.9x
P/E RatioIs PHIA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PHIA income statement (TTM) | |
|---|---|
| Revenue | €18.04b |
| Cost of Revenue | €10.43b |
| Gross Profit | €7.61b |
| Other Expenses | €8.08b |
| Earnings | -€469.00m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
Feb 03, 2025
| Earnings per share (EPS) | -0.50 |
| Gross Margin | 42.18% |
| Net Profit Margin | -2.60% |
| Debt/Equity Ratio | 69.4% |
How did PHIA perform over the long term?
See historical performance and comparison